Tuberculosis Biomarker and Surrogate Endpoint Research Roadmap-Reference-Cited by-同舟云学术

Tuberculosis Biomarker and Surrogate Endpoint Research Roadmap

Published:2011-10-15 Issue:8 Volume:184 Page:972-979
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Nahid Payam,Saukkonen Jussi,Kenzie William R. Mac,Johnson John L.,Phillips Patrick P. J.,Andersen Janet,Bliven-Sizemore Erin,Belisle John T.,Boom W. Henry,Luetkemeyer Annie,Campbell Thomas B.,Eisenach Kathleen D.,Hafner Richard,Lennox Jeffrey L.,Makhene Mamodikoe,Swindells Susan,Villarino M. Elsa,Weiner Marc,Benson Constance,Burman William

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference33 articles.

1. Global tuberculosis drug development pipeline: the need and the reality

2. Tuberculosis drug development pipeline: progress and hope

3. Bactericidal and Sterilizing Activities of Antituberculosis Drugs during the First 14 Days

4. Using Animal Models to Develop New Treatments for Tuberculosis

5. Biomarkers and Surrogate End Points in Clinical Trials of Tuberculosis Treatment

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A pharmacometric multistate model for predicting long-term treatment outcomes of patients with pulmonary TB;Journal of Antimicrobial Chemotherapy;2024-08-01

2. Tuberculosis treatment monitoring tests during routine practice: study design guidance;Clinical Microbiology and Infection;2024-04

3. Inflammatory immune profiles associated with disease severity in pulmonary tuberculosis patients with moderate to severe clinical TB or anemia;Frontiers in Immunology;2023-12-12

4. Balancing adjunctive therapy for tuberculosis treatment;The Lancet Infectious Diseases;2023-07

5. Discovery of Novel Transketolase Epitopes and the Development of IgG-Based Tuberculosis Serodiagnostics;Microbiology Spectrum;2023-02-14